Headquarters: Shanghai, China
CNY as of July 1, 2023
|Company||Market Cap (USD)|
|McKesson Corporation||$56.07 B|
|AmerisourceBergen Corporation||$39.09 B|
|Cardinal Health, Inc.||$24.00 B|
|Henry Schein, Inc.||$10.71 B|
|Sinopharm Group Co. Ltd||$9.50 B|
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through Production, Distribution, Retail, and Others segments. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestion and immune system, cardiovascular, anti-infection, nervous system and mental disorder, and oncology. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug retail business; and provision of consulting services, as well as in the assets management operations, etc. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 16 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.
Unlock the Power of Financial AI:
Try Disfold AI Free for 7 Days!